The Better Cat offers preventive cat food and supplements. The brand emphasizes the use of high-quality animal ingredients and aims to support various aspects of cat health.

The Better Cat

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Elanco Animal Health Incorporated

Virbac offers veterinarians, farmers, and pet owners a range of products and services focused on animal health, covering various species and diseases, self-described as contributing to the future of animal health.

Virbac

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Metric
Company Name	The Better Cat	Elanco Animal Health Incorporated	Virbac	Zoetis Inc.
Symbol		ELAN		ZTS
MSH ID	COM:THEBETTERCAT	COM:ELANCO	COM:VIRBAC	COM:ZOETIS
Market	PRIVATE	STOCKS	PRIVATE	STOCKS
Sector	Consumer Goods	Healthcare	Healthcare & Health Services	Healthcare
Industry	Pet Food	Drug Manufacturers - Specialty & Generic	Veterinary	Drug Manufacturers - Specialty & Generic
Country	DE	US	FR	US
Stage
Employee Count		9.30K		14.10K
Website	thebettercat.com	elanco.com	virbac.com	zoetis.com
LinkedIn				zoetis
Founders

Metric
Market Cap		6.56B	79.16B
Enterprise Value
Monthly Web Traffic	17.71K		457
Web Traffic Growth	0.14		-0.79
Valuation
Raised Capital

Metric
Revenue	4.42B	8.54B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.49B	5.83B
EBITDA	945M	3.56B
Operating Income	326M	3.07B
Net Income	-1.23B	2.34B
EPS	-2.50	5.08
Diluted EPS	-2.50	5.07
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.56	0.70
Operating Profit Margin	0.06	0.37
EBITDA Margin	0.21	0.42
Net Profit Margin	-0.28	0.27
Return on Equity	-0.18	0.49
Return on Assets	-0.09	0.17
Return on Capital Employed	0.02	0.27

COM:THEBETTERCAT

The Better Cat

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-6.79	38.27
P/B Ratio	1.27	17.18
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.09	9.98
EV Multiple	4.97	23.13

Metric
Days Sales Outstanding	94.80	54.81
Days Payables Outstanding	57.99	56.97
Days Inventory Outstanding	327.95	364.72
Operating Cycle	411.41	418.76
Cash Conversion Cycle	360.38	363.04
Asset Turnover	0.33	0.63

Metric
Operating Cash Flow	271M	2.35B
Free Cash Flow	117M	1.62B
Cash Flow to Debt	0.10	0.40
Operating Cash Flow/Sales	0.12	0.30
Free Cash Flow Yield	-0.01	0.02

Metric
Cash & Equivalents	352M	2.04B
Accounts Receivable	-40M	-102M
Inventory	1.74B	2.56B
Goodwill	5.09B	2.76B
Debt to Capitalization	0.49	0.58
Debt to Assets	0.41	0.48
Current Ratio	2.82	3.87
Quick Ratio	1.96	2.09

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.01
R&D to Revenue	0.08	0.07
SG&A to Revenue